Agenus Inc · Brief

Next report

9 days

Nov 9 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±14.0%implied · straddle

5.887.80

spot 6.84exp Nov 20ATM strike 7ATM straddle 1.12IV 85%

Oct 30 close

Expected move

Inputs

Implied vs realized

8 reportsHistory

—≥ implied

Nov 12 '24—▼−20.38%—

Mar 11 '25—▼−4.65%—

May 12 '25—▲+20.27%—

Aug 11 '25—▼−11.04%—

Q3 FY25—▲+5.78%—

Q1 FY26—▲+6.13%—

May 11 '26—▼−14.66%—

Q2 FY26±17.0%▼−3.73%×0.22

quarterimplied−25%0+25%realized×

Q2 FY26±17.0%▼−3.73%×0.22

May '26—▼−14.66%—

Q1 FY26—▲+6.13%—

Q3 FY25—▲+5.78%—

Aug '25—▼−11.04%—

May '25—▲+20.27%—

2 older reports

Mar '25—▼−4.65%—

Nov '24—▼−20.38%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

5.00%of revenue from the largest disclosed customer Zydus Lifesciences LtdSEC filings

103managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

6 of 20of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

14managers holding most of reported value13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

AGEN report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 26impliedImplied move: ±19.7% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.